A detailed history of Vanguard Group Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,266,773 shares of IDYA stock, worth $130 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,266,773
Previous 4,155,757 2.67%
Holding current value
$130 Million
Previous $182 Million 17.85%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$34.37 - $43.46 $3.82 Million - $4.82 Million
111,016 Added 2.67%
4,266,773 $150 Million
Q1 2024

May 10, 2024

BUY
$34.2 - $47.13 $23.3 Million - $32 Million
679,985 Added 19.56%
4,155,757 $182 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $12.4 Million - $18.1 Million
504,275 Added 16.97%
3,475,772 $124 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $2.99 Million - $4.22 Million
141,844 Added 5.01%
2,971,497 $80.2 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $6.78 Million - $13 Million
508,655 Added 21.92%
2,829,653 $66.5 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $420,834 - $583,989
31,196 Added 1.36%
2,320,998 $31.9 Million
Q4 2022

Feb 10, 2023

BUY
$14.47 - $18.17 $5.28 Million - $6.64 Million
365,202 Added 18.98%
2,289,802 $41.6 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $1.59 Million - $2.71 Million
171,759 Added 9.8%
1,924,600 $28.7 Million
Q2 2022

Aug 12, 2022

BUY
$8.28 - $13.88 $1.46 Million - $2.45 Million
176,584 Added 11.2%
1,752,841 $24.2 Million
Q1 2022

May 13, 2022

BUY
$11.18 - $24.02 $694,658 - $1.49 Million
62,134 Added 4.1%
1,576,257 $17.6 Million
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $2.06 Million - $2.64 Million
98,175 Added 6.93%
1,514,123 $35.8 Million
Q3 2021

Nov 12, 2021

BUY
$17.26 - $27.08 $5.95 Million - $9.34 Million
345,014 Added 32.22%
1,415,948 $36.1 Million
Q2 2021

Aug 13, 2021

BUY
$17.76 - $24.83 $19 Million - $26.6 Million
1,070,934 New
1,070,934 $22.5 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.47B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.